From Surf Wiki (app.surf) — the open knowledge base
Betamethasone
Steroid medication
Steroid medication
| Field | Value | |||
|---|---|---|---|---|
| Watchedfields | changed | |||
| verifiedrevid | 459977512 | |||
| image | Betamethasone.svg | |||
| image_class | skin-invert-image | |||
| image2 | Betamethasone2.png | |||
| image_class2 | bg-transparent | |||
| tradename | Celestone, Eleuphrat, others | |||
| Drugs.com | ||||
| MedlinePlus | a682799 | |||
| DailyMedID | Betamethasone | |||
| pregnancy_AU | C | |||
| pregnancy_AU_comment | ||||
| routes_of_administration | By mouth, topical, intramuscular | |||
| ATC_prefix | A07 | |||
| ATC_suffix | EA04 | |||
| ATC_supplemental | ||||
| legal_AU | S4 | |||
| legal_BR | ||||
| legal_CA | ||||
| legal_DE | ||||
| legal_NZ | ||||
| legal_UK | POM | |||
| legal_UK_comment | ||||
| legal_US | Rx-only | |||
| legal_UN | ||||
| legal_status | Rx-only | |||
| metabolism | Liver CYP3A4 | |||
| elimination_half-life | 36-54 hours | |||
| excretion | Kidney (in urine) | |||
| CAS_number_Ref | ||||
| CAS_number | 378-44-9 | |||
| PubChem | 9782 | |||
| IUPHAR_ligand | 7061 | |||
| DrugBank_Ref | ||||
| DrugBank | DB00443 | |||
| ChemSpiderID_Ref | ||||
| ChemSpiderID | 9399 | |||
| UNII_Ref | ||||
| UNII | 9842X06Q6M | |||
| KEGG_Ref | ||||
| KEGG | D00244 | |||
| ChEBI_Ref | ||||
| ChEBI | 3077 | |||
| ChEMBL_Ref | ||||
| ChEMBL | 632 | |||
| IUPAC_name | (8S,9R,10S,11S,13S,14S,16S,17R)-9-Fluoro- 11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro- 3H-cyclopenta[a]phenanthren-3-one | |||
| C | 22 | H=29 | F=1 | O=5 |
| SMILES | O=C(CO)[C@]3(O)[C@]2(CC@H[C@]4(F)[C@@]/1(\C(=C/C(=O)\C=C\1)CC[C@H]4[C@@H]2C[C@@H]3C)C)C | |||
| StdInChI_Ref | ||||
| StdInChI | 1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1 | |||
| StdInChIKey_Ref | ||||
| StdInChIKey | UREBDLICKHMUKA-DVTGEIKXSA-N |
| Drugs.com =
| elimination_half-life = 36-54 hours
Betamethasone is a steroid medication. It is used for a number of diseases including rheumatic disorders such as rheumatoid arthritis and systemic lupus erythematosus, skin diseases such as dermatitis and psoriasis, allergic conditions such as asthma and angioedema, preterm labor to speed the development of the baby's lungs, Crohn's disease, cancers such as leukemia, and along with fludrocortisone for adrenocortical insufficiency, among others.
Serious side effects include an increased risk of infection, muscle weakness, severe allergic reactions, and psychosis.
Betamethasone was patented in 1958, and approved for medical use in the United States in 1961. It is on the World Health Organization's List of Essential Medicines. It is available as a generic medication.
Medical uses
Betamethasone is a corticosteroid that is available as a pill, by injection, and as an ointment, cream, lotion, gel, or aerosol (spray) for the skin, and a foam for the scalp. When given by injection, anti-inflammatory effects begin in around two hours and last for seven days.
It is used as a topical cream to relieve skin irritation, such as itching and flaking from eczema. It is used as a treatment for local psoriasis, as betamethasone dipropionate and salicylic acid, or as the combination calcipotriol/betamethasone dipropionate. Betamethasone sodium phosphate is used orally and via injection with the same indications as other steroids. Many betamethasone-based pharmaceuticals include the steroid as the valerate ester.
In a randomized controlled trial betamethasone was shown to reduce some of the ataxia (poor coordination) symptoms associated with ataxia telangiectasia (A-T) by 28-31%.
Betamethasone is also used to stimulate fetal maturation of the lungs and cerebral blood vessels.
A cream with 0.05% betamethasone appears effective in treating phimosis in boys, and often averts the need for circumcision. Longer-term research is needed on this treatment method. This approach has replaced circumcision as the preferred treatment method for some physicians in the British National Health Service.
Side effects
- Euphoria
- Depression
- Adrenal suppression
- Hypertension
- Groupings of fine blood vessels becoming prominent under the skin, petechiae
- Excessive hair growth (hypertrichosis)
- Ecchymoses
Betamethasone crosses the placenta.
When injected into the epidural space or the spine, it may cause serious side effects like loss of vision, stroke, and paralysis.
Pharmacology
Main article: Glucocorticoid#Pharmacology
Forms
Betamethasone is available in a number of compound forms: betamethasone dipropionate (branded as Diprosone, Diprolene, Celestamine, Procort (in Pakistan), and others), betamethasone sodium phosphate (branded as Bentelan in Italy) and betamethasone valerate (branded as Audavate, Betnovate, Celestone, Fucibet, and others). In the United States and Canada, betamethasone is mixed with clotrimazole and sold as Lotrisone and Lotriderm. It is also available in combination with salicylic acid (branded as Diprosalic) for using in psoriatic skin conditions. In some countries, it is also sold mixed with both clotrimazole and gentamicin to add an antibacterial agent to the mix.
Betamethasone sodium phosphate mixed with betamethasone acetate is available in the United States as Celestone Soluspan.
References
References
- (30 December 2019). "Betamethasone Use During Pregnancy".
- (5 April 2018). "Betamethasone 500 microgram Soluble Tablets - Summary of Product Characteristics (SmPC)".
- "Betamethasone". The American Society of Health-System Pharmacists.
- "Betamethasone topical". The American Society of Health-System Pharmacists.
- (2023). "The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023)". World Health Organization.
- "Betamethasone Drug Usage Statistics, United States, 2014 - 2023".
- (19 March 2020). "Betamethasone Topical".
- (September 2012). "A randomized trial of oral betamethasone to reduce ataxia symptoms in ataxia telangiectasia". Movement Disorders.
- (January 2024). "Topical corticosteroids for treating phimosis in boys". The Cochrane Database of Systematic Reviews.
- (October 1998). "Cost-effective treatment of phimosis". Pediatrics.
- (April 2008). "Topical steroid application versus circumcision in pediatric patients with phimosis: a prospective randomized placebo controlled clinical trial". Springer Science and Business Media LLC.
- (April 2007). "Phimosis and topical steroids: new clinical findings". Pediatric Surgery International.
- (February 2001). "Cost-effectiveness analysis of treatments for phimosis: a comparison of surgical and medicinal approaches and their economic effect". BJU International.
- (September 1999). "Topical steroid treatment of phimosis in boys". The Journal of Urology.
- (2017). "betamethasone". F.A. Davis.
- (23 April 2014). "FDA Drug Safety Communication: FDA requires label changes to warn of rare but serious neurologic problems after epidural corticosteroid injections for pain".
- (18 November 2019). "Celestone Soluspan- betamethasone acetate and betamethasone sodium phosphate injection, suspension".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Betamethasone — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report